Pay in 4 interest-free payments of $6.64 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Increasing Awareness of GLP-1 Therapies Awareness of GLP-1 receptor agonists as effective treatment options for diabetes is steadily increasing in India
Einzelnachweise Rebouche CJ
Well conduct a comprehensive metabolic evaluation, determine candidacy, and build a personalized GLP-1 program designed to deliver sustainable results not just short-term weight loss.
doi: 10.1053/j.ackd.2014.11.004 38 MatsusakaTNiimuraFShimizuAPastanISaitoAKoboriHet al
Cell Metab (2006) 3(3):15365
GLP-1s in CKD: Evidence, market leadership, and key insights from ASN 2025 At ASN Kidney Week 2025, Glucagon-like peptide-1 (GLP-1) receptor agonists moved firmly into the nephrology spotlight, with more than 70 sessions, posters, and oral abstracts probing their role across the kidney-disease continuum, and even a dedicated mention during the opening plenary talk
US$ 22.05
US$ 26.73
US$ 21.36
US$ 28.42
US$ 28.80
US$ 21.53
